標普和納斯達克內在價值 聯繫我們
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← 返回所有股票

Becton, Dickinson and Company BDXB NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
64/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Becton, Dickinson and Company (BDXB) 是一家 Medical - Instruments & Supplies 公司，屬於 醫療保健 產業, 目前交易價格為 $48.16. 其SharesGrow評分為 64/100, 表明 高於平均 的投資特徵， 7項中通過3項.

財務數據: 營收為 $21.8B, +5%/yr 平均成長. 淨利潤為 $1.7B, 成長率為 -1.1%/yr. 淨利潤率為 7.7% (較薄). 毛利率為 45.4% (+0.5 pp 趨勢).

資產負債表: 總債務為 $19.2B 對比 $25.4B 股東權益 (D/E比率 0.76, 適度). 流動比率為 1.11 (充足). 資產負債率為 34.7%. 總資產: $55.3B.

分析師展望: 16 / 30 位分析師評級 BDXB 為買入 (53%) — 適度共識.

SharesGrow 7項標準細分: Value 100/100 (Pass), Growth 40/100 (Partial), Past 100/100 (Pass), Health 50/100 (Partial), Moat 73/100 (Pass), Future 40/100 (Partial), Income 45/100 (Partial).

BDXB SharesGrow 評分概覽

64/100
SharesGrow Score
Above average fundamentals
View full scorecard →
價值 100/100
估值 — P/E, PEG, Forward PEG
成長 40/100
財務數據 — 平均成長
過去 100/100
強勁 — 趨勢
健康 50/100
資產負債表 — D/E比率, 流動比率為
護城河 73/100
毛利率為 + market cap
未來 40/100
分析師展望 — 為買入
收入 45/100
淨利潤率為
Scores derived from financial statements, analyst ratings, and balance sheet data.

評分明細 — BDXB

✓
價值 Pass
100/100
BDXB 本益比(P/E)為 N/A (S&P 500平均約25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + 上漲空間 (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
~
成長 Partial
40/100
BDXB: +5%/yr 營收為, -1.1%/yr 淨利潤為 平均成長. 一般. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
✓
過去 Pass
100/100
BDXB: 4 / 4 年獲利. 強勁 — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
~
健康 Partial
50/100
資產負債表 BDXB: D/E比率 0.76 (適度), 流動比率為 1.11 (充足). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✓
護城河 Pass
73/100
BDXB: 毛利率為 45.4% (+0.5 pp 趨勢), $14B market cap. Moat (0-100): margin (35%) + 趨勢 (15%) + market cap (30%) + 營收為 (20%). Score 73/100. ≥ 70 = Pass.
View details →
~
未來 Partial
40/100
分析師展望: 16 / 30 位分析師評級 BDXB 為買入 (53%). Score: 60% buy consensus + 40% 上漲空間. ≥ 60 = Pass.
View details →
~
收入 Partial
45/100
BDXB: 淨利潤率為 7.7%. 較薄 (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

市場數據
52週區間45.85-52.52
成交量2.76M
30日平均成交量449.58K
市值$13.69B
Beta（1年）0.56
股息率$3.0000
Share Statistics
EPS（TTM）5.84
流通股數$286.61M
IPO Date2020-05-21
Employees77,000
CEOThomas E. Polen Jr.
Financial Highlights & Ratios
Revenue (TTM)$21.84B
Gross Profit$9.92B
EBITDA$4.96B
Net Income$1.68B
Operating Income$2.58B
Total Cash$859M
Total Debt$19.18B
Net Debt$18.33B
Total Assets$55.33B
Price / Earnings (P/E)8.2
Price / Sales (P/S)0.63
Analyst Forecast
評級共識Buy
覆蓋分析師數30
買入 53% 持有 43% 賣出 3%
公司資訊
國家US
交易所NYSE
貨幣USD
ISINUS0758874061

股價走勢

Track all markets on TradingView
BDXB
Becton, Dickinson and Company ↗  ·  NYSE
Healthcare • Medical - Instruments & Supplies
45.85 52WK RANGE 52.52

其他人也在看

BSX-PA
BSX-PA
Boston Scientific Corporation
$122.18
+2.37%
 BHFAP
BHFAP
Brighthouse Financial, Inc.
$16.43
+1.23%
 BHFAO
BHFAO
Brighthouse Financial, Inc.
$16.98
+1.49%
 BHFAN
BHFAN
Brighthouse Financial, Inc.
$13.39
+0.45%
 AEPPZ
AEPPZ
American Electric Power Company, Inc.
$47.12
-1.09%
 LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
聯繫我們
🎓
SharesGrow 學院
學習如何計算內在價值，發現被低估的股票。
每週線上課程
📧 [email protected]
📞 +65 8912 8000
給我們留言